Onyx Prepares for Multiple Bids After Amgen Snub
July 23 (Bloomberg) -- Bloomberg Industries' Sam Fazeli examines the possible suitors for Onyx Pharmaceuticals as Astrazeneca, Pfizer and Novartis are said to be preparing offers for the drugmaker. He speaks on Bloomberg Television's "On The Move."
Most Recent Videos
Full Show: Bloomberg Daybreak: Americas (03/23)
57:32 - Bloomberg Daybreak: Americas hosted by Jonathan Ferro and Alix Steel. Guests include Harvard Kennedy School Professor Nicholas Burns, Torsten Slok, chief international economist at Deutsche Bank, Yianos Kontopoulos, global head of macro strategy at UBS, Amer Bisat, emerging markets portfolio manager at BlackRock Strategic Global Bond Fund, Federico Schiffrin, partner of private equity at Unigestion SA, Keith Parker, U.S. head of asset allocation at Barclays Capital Inc., Jacob Kirkegaard, senior fellow at Peterson Institute for International Economics, and Matthew Shay, chief executive officer at National Retail Federation. (Source: Bloomberg)